Agios Pharmaceuticals | Capitale Sociale E Riserve

Equity Capital And Reserves Cambiamento Data
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amgen USD 6.23B 1.42B 2023-12
Arrowhead Research USD 160.41M 110.94M 2023-12
AstraZeneca USD 37.2B 195M 2023-09
Bayer EUR 33.38B 3.57B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Exelixis USD 2.35B 180.32M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
GlaxoSmithKline GBP 13.13B 442M 2023-09
Incyte USD 5.19B 258.39M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Moderna USD 13.85B 399M 2023-12
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Roche Holding CHF 26.52B 1.48B 2023-06
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Agios Pharmaceuticals Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.